Freestone Capital Holdings »

Cartesian Therapeutics shares owned by Freestone Capital Holdings

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Freestone Capital Holdings from 13F filings

Historical chart of Freestone Capital Holdings investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Freestone Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Freestone Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-12-31 $464k 26k 17.91
2024-06-30 $216k 8.0k 27.01

More positions owned by Freestone Capital Holdings

Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation Put Option (MSFT)
NVIDIA Corporation (NVDA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)
Amazon (AMZN)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Nike CL B (NKE)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)

View all positions for Freestone Capital Holdings

Top funds holding Cartesian Therapeutics

FMR
MPM Oncology Impact Management
BlackRock
Siren
Vanguard Group
Citadel Advisors
Jpmorgan Chase & Co
Geode Capital Management
Erste Asset Management GmbH
State Street Corporation
683 Capital Management
Northern Trust
Nuveen Asset Management
Ikarian Capital
Goldman Sachs Group

View all funds holding Cartesian Therapeutics